TXNIP and diabetic kidney disease: Exenatide mediates attenuation of diabetic nephropathy by SIRT1-dependent down-regulation of thioredoxin-interacting protein H3K9ac acetylation and reduces the recruitment of spliced X-box binding protein 1 to the Txnip promoter [43].